Exosome‐Functionalized Self‐Carrier Enzyme‐Like/Drug With Triple Amplified Anti‐Oxidative Stress for Synergistic Depression Therapy
Small · 2025-06 · 21 (24)
DOI: 10.1002/smll.202411030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 22.04.2025. Verfasst von Hanqing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy & Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ningxia Medical University…. Hauptthemen laut MEDLINE: Oxidative Stress, Exosomes, Depression, Antioxidants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Key research and development projects of Ningxia, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
Depression, a severe disorder affecting both physical and mental health, is commonly treated with first‐line antidepressants, which often exhibit limited efficacy due to poor penetration of the blood‐brain barrier (BBB) and significant side effects, thus requiring the exploitation of biocompatible and effective treatments. Recent studies suggest that depression is closely linked to an imbalance in oxidative stress and subsequent inflammatory responses. Antioxidant therapies and targeting oxidative stress in inflammatory depression are therefore emerging as promising strategies. In this study, an exosome‐functionalized and geniposide (GEN) self‐carried Prussian blue (PB) nanotherapeutic approach is fabricated to realize efficient BBB penetration for synergistic depression therapy. The porous PB carrier possesses multi‐enzyme capabilities, which can effectively scavenge the accumulated ROS, protecting the slightly inflammatory acidic environment released GEN from oxidation, and the GEN subsequently works simultaneously with PB to activate the Nrf2‐ARE pathway, enhancing the body's oxidative stress defense mechanisms synergistically. The triple‐amplified anti‐oxidant strategy of this nanomaterial is shown to mitigate microglial activation and the reduction in neuroplasticity, ultimately alleviating the pathological markers of inflammatory depression. Overall, the constructed nanomaterials underscore the therapeutic potential of anti‐oxidative stress for synergistic removal of ROS and activation of the Nrf2‐ARE pathway in the treatment of inflammatory depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy & Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ningxia Medical University, Yinchuan, 750004, China.
- School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of General Surgery, Nanjing Drum Tower Hospital, Nanjing, 210023, China.
- School of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
ORCID-Profile: Hui Wang, Weiwei Tao
Förderung
- Key research and development projects of Ningxia
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Xu, Y., Zhang, Z., Luo, B., Hou, D., Lu, Y., Xie, M., Guan, W., Peng, J., Wang, H., & Tao, W. (2025). Exosome‐Functionalized Self‐Carrier Enzyme‐Like/Drug With Triple Amplified Anti‐Oxidative Stress for Synergistic Depression Therapy. Small, 21(24). https://doi.org/10.1002/smll.202411030
Vancouver
Wang H, Xu Y, Zhang Z, Luo B, Hou D, Lu Y, et al. Exosome‐Functionalized Self‐Carrier Enzyme‐Like/Drug With Triple Amplified Anti‐Oxidative Stress for Synergistic Depression Therapy. Small. 2025;21(24). doi:10.1002/smll.202411030
BibTeX
@article{Wang2025,
author = {Wang, Hanqing and Xu, Yunzhu and Zhang, Zicheng and Luo, Banxin and Hou, Dahai and Lu, Youyuan and Xie, Mingxia and Guan, Wenxian and Peng, Jinlei and Wang, Hui and Tao, Weiwei},
title = {Exosome‐Functionalized Self‐Carrier Enzyme‐Like/Drug With Triple Amplified Anti‐Oxidative Stress for Synergistic Depression Therapy},
journal = {Small},
year = {2025},
volume = {21},
number = {24},
doi = {10.1002/smll.202411030}
}
EUVIMED